Product Datasheet
www.leinco.com
excellence in early discovery research       



Act1 (NT) Blocking Peptide
(CIKS, C6orf2,C6orf4, ,6orf5, C6orf6, MGC3581, DKFZp586G0522, TRAF3IP2)
Blocking Peptide
Share |

Size


Prod. No.:A188
Conc.:0.2 mg/ml
Pkg. Size:50 µg
Storage:-20°C Detailed storage instructions below.
Description
Background:
Act1 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Amino Acid Location
This peptide sequence is located at amino acids 2 to 15 of Human Act1 protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Stability
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
References
1. Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA. 2000;97(19):10494-9.

2. Li X, Commane M, Nie H, Hua X, Chatterjee-Kishore M, Wald D, Haag M, Stark GR. Act1, an NF-kappa B activating protein. Proc Natl Acad Sci USA. 2000;97(19):10489-93.
Related Products
Act1 (CT) Blocking Peptide (Leinco Prod. No.: A190)
Anti-Human Act1 (CT) (Leinco Prod. No.: A189)
Anti-Human Act1 (NT) (Leinco Prod. No.: A187)
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
359 Consort Drive | St. Louis, MO 63011 | (800) 538-1145 | (636) 527-5545 fax
800.538.1145 ® Copyright Leinco Technologies, Inc. 2006 – 2012